-
1
-
-
43349104741
-
Advances in mechanisms of repair and remodelling in acute lung injury
-
Dos Santos C.C. Advances in mechanisms of repair and remodelling in acute lung injury. Intensive Care Med. 2008, 34:619-630.
-
(2008)
Intensive Care Med.
, vol.34
, pp. 619-630
-
-
Dos Santos, C.C.1
-
2
-
-
53249096079
-
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome
-
Raghavendran K., Pryhuber G.S., Chess P.R., Davidson B.A., Knight P.R., Notter R.H. Pharmacotherapy of acute lung injury and acute respiratory distress syndrome. Curr. Med. Chem. 2008, 15:1911-1924.
-
(2008)
Curr. Med. Chem.
, vol.15
, pp. 1911-1924
-
-
Raghavendran, K.1
Pryhuber, G.S.2
Chess, P.R.3
Davidson, B.A.4
Knight, P.R.5
Notter, R.H.6
-
3
-
-
0033796308
-
Pulmonary pathology of acute respiratory distress syndrome
-
Tomashefski J.F. Pulmonary pathology of acute respiratory distress syndrome. Clin. Chest Med. 2000, 21:435-466.
-
(2000)
Clin. Chest Med.
, vol.21
, pp. 435-466
-
-
Tomashefski, J.F.1
-
4
-
-
0141926684
-
The pathophysiology of acute respiratory distress syndrome
-
Dechert R.E. The pathophysiology of acute respiratory distress syndrome. Respir. Care Clin. N. Am. 2003, 9:283-296.
-
(2003)
Respir. Care Clin. N. Am.
, vol.9
, pp. 283-296
-
-
Dechert, R.E.1
-
5
-
-
0035018051
-
Acute lung injury: cellular mechanisms and derangements
-
Schwarz M.A. Acute lung injury: cellular mechanisms and derangements. Paediatr. Respir. Rev. 2001, 2:3-9.
-
(2001)
Paediatr. Respir. Rev.
, vol.2
, pp. 3-9
-
-
Schwarz, M.A.1
-
6
-
-
67651099181
-
Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease
-
Yamagishi S., Nakamura K., Matsui T. Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease. Pharmacol. Res. 2009, 60:174-178.
-
(2009)
Pharmacol. Res.
, vol.60
, pp. 174-178
-
-
Yamagishi, S.1
Nakamura, K.2
Matsui, T.3
-
7
-
-
77957583005
-
The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?
-
Creagh-Brown B.C., Quinlan G.J., Evans T.W., Burke-Gaffney A. The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?. Intensive Care Med. 2010, 36:1644-1656.
-
(2010)
Intensive Care Med.
, vol.36
, pp. 1644-1656
-
-
Creagh-Brown, B.C.1
Quinlan, G.J.2
Evans, T.W.3
Burke-Gaffney, A.4
-
8
-
-
77952298772
-
HMGB1 and RAGE in inflammation and cancer
-
Sims G.P., Rowe D.C., Rietdijk S.T., Herbst R., Coyle A.J. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 2010, 28:367-388.
-
(2010)
Annu. Rev. Immunol.
, vol.28
, pp. 367-388
-
-
Sims, G.P.1
Rowe, D.C.2
Rietdijk, S.T.3
Herbst, R.4
Coyle, A.J.5
-
9
-
-
77955703092
-
RAGE: a multi-ligand receptor unveiling novel insights in health and disease
-
Alexiou P., Chatzopoulou M., Pegklidou K., Demopoulos V.J. RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr. Med. Chem. 2010, 21:2232-2252.
-
(2010)
Curr. Med. Chem.
, vol.21
, pp. 2232-2252
-
-
Alexiou, P.1
Chatzopoulou, M.2
Pegklidou, K.3
Demopoulos, V.J.4
-
10
-
-
0034795140
-
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
-
Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 2001, 108:949-955.
-
(2001)
J. Clin. Invest.
, vol.108
, pp. 949-955
-
-
Schmidt, A.M.1
Yan, S.D.2
Yan, S.F.3
Stern, D.M.4
-
11
-
-
0037769813
-
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells
-
Fiuza C., Bustin M., Talwar S., et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-2660.
-
(2003)
Blood
, vol.101
, pp. 2652-2660
-
-
Fiuza, C.1
Bustin, M.2
Talwar, S.3
-
12
-
-
1542285224
-
Amphoterin as an extracellular regulator of cell motility: from discovery to disease
-
Huttunen H.J., Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J. Intern. Med. 2004, 255:351-366.
-
(2004)
J. Intern. Med.
, vol.255
, pp. 351-366
-
-
Huttunen, H.J.1
Rauvala, H.2
-
13
-
-
0034664791
-
Cutting edge: HMGB1 as a mediator of acute lung inflammation
-
Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K.J. Cutting edge: HMGB1 as a mediator of acute lung inflammation. J. Immunol. 2000, 165:2950-2954.
-
(2000)
J. Immunol.
, vol.165
, pp. 2950-2954
-
-
Abraham, E.1
Arcaroli, J.2
Carmody, A.3
Wang, H.4
Tracey, K.J.5
-
14
-
-
34547094102
-
High-mobility group box 1 protein plasma concentrations during septic shock
-
Gibot S., Massin F., Cravoisy A., et al. High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med. 2007, 33:1347-1353.
-
(2007)
Intensive Care Med.
, vol.33
, pp. 1347-1353
-
-
Gibot, S.1
Massin, F.2
Cravoisy, A.3
-
15
-
-
33947660493
-
High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study
-
Gaini S., Pedersen S.S., Koldkjaer O.G., Pedersen C., Moller H.J. High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study. Crit. Care 2007, 11:R32.
-
(2007)
Crit. Care
, vol.11
-
-
Gaini, S.1
Pedersen, S.S.2
Koldkjaer, O.G.3
Pedersen, C.4
Moller, H.J.5
-
16
-
-
48949095796
-
Role of soluble receptor for advanced glycation end products on exdotoxin-induced lung injury
-
Zhang H., Tasaka S., Shiraishi Y., et al. Role of soluble receptor for advanced glycation end products on exdotoxin-induced lung injury. Am. J. Respir. Crit. Care Med. 2008, 178:356-362.
-
(2008)
Am. J. Respir. Crit. Care Med.
, vol.178
, pp. 356-362
-
-
Zhang, H.1
Tasaka, S.2
Shiraishi, Y.3
-
17
-
-
38349179648
-
Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging
-
Yan S.F., D'Agati V., Schmidt A.M., Ramasamy R. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Curr. Mol. Med. 2007, 7:699-710.
-
(2007)
Curr. Mol. Med.
, vol.7
, pp. 699-710
-
-
Yan, S.F.1
D'Agati, V.2
Schmidt, A.M.3
Ramasamy, R.4
-
18
-
-
77957345420
-
Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker
-
Yamagishi S., Matsui T. Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker. Front. Biosci. 2010, 2:1184-1195.
-
(2010)
Front. Biosci.
, vol.2
, pp. 1184-1195
-
-
Yamagishi, S.1
Matsui, T.2
-
20
-
-
33646243227
-
Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury
-
Uchida T., Shirasawa M., Ware L.B., et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 2006, 173:1008-1015.
-
(2006)
Am. J. Respir. Crit. Care Med.
, vol.173
, pp. 1008-1015
-
-
Uchida, T.1
Shirasawa, M.2
Ware, L.B.3
-
21
-
-
67650069965
-
Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury
-
Su X., Looney M.R., Gupta N., Matthay M.A. Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L1-L5.
-
(2009)
Am. J. Physiol. Lung Cell. Mol. Physiol.
, vol.297
-
-
Su, X.1
Looney, M.R.2
Gupta, N.3
Matthay, M.A.4
-
22
-
-
0028267785
-
The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination
-
Bernard G.R., Artigas A., Brigham K.L., et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Am. J. Respir. Crit. Care Med. 1994, 149:818-824.
-
(1994)
Am. J. Respir. Crit. Care Med.
, vol.149
, pp. 818-824
-
-
Bernard, G.R.1
Artigas, A.2
Brigham, K.L.3
-
23
-
-
0022256529
-
APACHE II: a severity of disease classification system
-
Knaus W., Draper E., Wagner D., Zimmerman J. APACHE II: a severity of disease classification system. Crit. Care Med. 1985, 13:818-829.
-
(1985)
Crit. Care Med.
, vol.13
, pp. 818-829
-
-
Knaus, W.1
Draper, E.2
Wagner, D.3
Zimmerman, J.4
-
24
-
-
0023719313
-
An expanded definition of the adult respiratory distress syndrome
-
Murray J.F., Matthay M.A., Luce J.M., Flick M.R. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1988, 138:720-723.
-
(1988)
Am. Rev. Respir. Dis.
, vol.138
, pp. 720-723
-
-
Murray, J.F.1
Matthay, M.A.2
Luce, J.M.3
Flick, M.R.4
-
25
-
-
2442676627
-
Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome
-
Ishizaka A., Matsuda T., Albertine K.H., et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286:L1088-L1094.
-
(2004)
Am. J. Physiol. Lung Cell. Mol. Physiol.
, vol.286
-
-
Ishizaka, A.1
Matsuda, T.2
Albertine, K.H.3
-
26
-
-
33747832531
-
New high mobility group box-1 assay system
-
Yamada S., Yakabe K., Ishii J., Imaizumi H., Maruyama I. New high mobility group box-1 assay system. Clin. Chin. Acta 2006, 372:173-178.
-
(2006)
Clin. Chin. Acta
, vol.372
, pp. 173-178
-
-
Yamada, S.1
Yakabe, K.2
Ishii, J.3
Imaizumi, H.4
Maruyama, I.5
-
27
-
-
70350168702
-
Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock
-
Nakamura K., Sato E., Fujiwara N., et al. Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock. Pharmacol. Res. 2009, 60:515-518.
-
(2009)
Pharmacol. Res.
, vol.60
, pp. 515-518
-
-
Nakamura, K.1
Sato, E.2
Fujiwara, N.3
-
28
-
-
39649118422
-
Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes
-
Nakamura K., Yamagishi S., Adachi H., et al. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Diabetes Metab. Res. Rev. 2008, 24:109-114.
-
(2008)
Diabetes Metab. Res. Rev.
, vol.24
, pp. 109-114
-
-
Nakamura, K.1
Yamagishi, S.2
Adachi, H.3
-
29
-
-
57149101367
-
NHLBI ARDS Network, plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury
-
Calfee C.S., Ware L.B., Eisner M.D., et al. NHLBI ARDS Network, plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008, 63:1083-1089.
-
(2008)
Thorax
, vol.63
, pp. 1083-1089
-
-
Calfee, C.S.1
Ware, L.B.2
Eisner, M.D.3
-
30
-
-
0343893748
-
The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
-
The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 2000, 342:1301-1308.
-
(2000)
N. Engl. J. Med.
, vol.342
, pp. 1301-1308
-
-
-
31
-
-
54049108485
-
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
-
Raucci A., Cugusi S., Antonelli A., et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 2008, 22:3716-3727.
-
(2008)
FASEB J.
, vol.22
, pp. 3716-3727
-
-
Raucci, A.1
Cugusi, S.2
Antonelli, A.3
-
32
-
-
27744574284
-
Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension
-
Nakamura K., Yamagishi S., Nakamura Y., et al. Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvasc. Res. 2005, 70:137-141.
-
(2005)
Microvasc. Res.
, vol.70
, pp. 137-141
-
-
Nakamura, K.1
Yamagishi, S.2
Nakamura, Y.3
-
33
-
-
33947408459
-
Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes
-
Tan K.C., Shiu S.W., Chow W.S., Leng L., Bucala R., Betteridge D.J. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia 2006, 49:2756-2762.
-
(2006)
Diabetologia
, vol.49
, pp. 2756-2762
-
-
Tan, K.C.1
Shiu, S.W.2
Chow, W.S.3
Leng, L.4
Bucala, R.5
Betteridge, D.J.6
-
34
-
-
33947386181
-
Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
-
Humpert P.M., Djuric Z., Kopf S., et al. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes. Cardiovasc. Diabetol. 2007, 6:9.
-
(2007)
Cardiovasc. Diabetol.
, vol.6
, pp. 9
-
-
Humpert, P.M.1
Djuric, Z.2
Kopf, S.3
-
35
-
-
45449083028
-
Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes
-
Nakamura K., Yamagishi S., Adachi H., et al. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes. Microvasc. Res. 2008, 76:52-56.
-
(2008)
Microvasc. Res.
, vol.76
, pp. 52-56
-
-
Nakamura, K.1
Yamagishi, S.2
Adachi, H.3
-
36
-
-
34250675234
-
Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes
-
Nakamura K., Yamagishi S., Adachi H., et al. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol. Med. 2007, 13:185-189.
-
(2007)
Mol. Med.
, vol.13
, pp. 185-189
-
-
Nakamura, K.1
Yamagishi, S.2
Adachi, H.3
-
37
-
-
0033538467
-
HMG-1 as a late mediator of endotoxin lethality in mice
-
Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
-
(1999)
Science
, vol.285
, pp. 248-251
-
-
Wang, H.1
Bloom, O.2
Zhang, M.3
-
38
-
-
45549107924
-
Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis
-
Bopp C., Bierhaus A., Hofer S., et al. Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit. Care 2008, 12:201.
-
(2008)
Crit. Care
, vol.12
, pp. 201
-
-
Bopp, C.1
Bierhaus, A.2
Hofer, S.3
-
39
-
-
43049145039
-
SRAGE is elevated in septic patients and associated with patients outcome
-
Bopp C., Hofer S., Weitz J., et al. sRAGE is elevated in septic patients and associated with patients outcome. J. Surg. Res. 2008, 147:79-83.
-
(2008)
J. Surg. Res.
, vol.147
, pp. 79-83
-
-
Bopp, C.1
Hofer, S.2
Weitz, J.3
|